[Home]
[Full version]
New peritoneal dialysis diagnostic discovered
Oct 17 ,Medicine & Health
Thanks to a discovery by scientists at Robarts Research Institute and The University of Western Ontario, patients undergoing peritoneal dialysis may soon be able to worry less about the risks of infection and lessen their hospital stays.
Peritoneal dialysis, which involves placing a tube into the peritoneal cavity, allows people who have suffered from kidney failure to carry on a relatively normal life; however, complications include high incidence of infection of the abdominal cavity, known as peritonitis, which most patients experience every year or so.
Led by Joaquin Madrenas, Robarts scientist and Canada Research Chair in Immunobiology at Western, the study has looked at the molecule RIP2 (receptor-interacting protein 2) for clues over the past three years. Though the precise function of RIP2 is not yet known, scientists made the important finding that levels of the molecule increase during infection. More importantly, peritoneal dialysis patients with peritonitis who have high levels of RIP2 can be sent home and treated with antibiotics. If RIP2 levels do not go up, patients risk a protracted infection and should be admitted for closer monitoring and more intense treatment. This information can be used to address the need to admit patients to the hospital.
“We currently have no objective indicator if peritonitis will be really bad, so we tend to try to guess how bad it is,” says Madrenas. “What we have found is that, by monitoring RIP2, we can predict the outcome of the infection in patients taking part in peritoneal dialysis.”
By keeping patients out of hospitals, this discovery not only helps improve quality of life, but also reduces strain on the healthcare system.
The team, which includes Madrenas’ PhD student Michelle McCully and a close collaboration with Dr. Peter Blake of the division of nephrology at Western, will now try to adapt the discovery to a clinical laboratory and hopefully develop a diagnostic test that can be conducted with a patient’s peritoneal fluid on a routine basis. Madrenas also wonders if there are other factors preventing RIP2 levels from increasing in some patients. “If we know what problem is preventing this increase, we could fix it and possibly prevent infections,” he says.
Source: University of Western Ontario
Related stories:
Surgical treatment provides new option for some colorectal cancer patients
Research out of Wake Forest University School of Medicine suggests that a surgical technique not traditionally used in advanced abdominal cancer may be a viable treatment option for some patients previously thought to be untreatable, offering the real possibility of extending survival for those patients.
Investigational drug shows promise in ovarian cancer
An investigational drug that combats ovarian cancer by inhibiting the formation of new blood vessels has shown promise in a phase II trial, according to a presentation at the 33rd Congress of the European Society for Medical Oncology (ESMO) in Stockholm.
Drug lowers body's 'set point' to control hyperparathyroidism in dialysis patients
A medication called cinacalcet—an important part of treatment to control high levels of parathyroid hormone (PTH) in patients receiving dialysis for end-stage renal disease (ESRD)—works by resetting the balance between calcium and PTH levels, according to a study in the November
Journal of the American Society of Nephrology (JASN).
Researchers design model for automated, wearable artificial kidney
Two researchers from UCLA and the Veterans Affairs Greater Los Angeles Healthcare System have developed a design for an automated, wearable artificial kidney, or AWAK, that avoids the complications patients often suffer with traditional dialysis.
Where college students live can impact their weight, eating and exercise habits
Endometriosis is a poorly understood condition that incapacitates and affects the productivity and lifestyle of millions of women around the world. In the US, it affects approximately six million women and adolescents at a cost of some $1.6 billion per year. It is a chronic painful disease which occurs when endometrial tissue grows as lesions outside the uterus, mainly in the area of the ovaries and fallopian tubes, but can also affect the intestinal tract. The condition results in chronic pelvic pain, painful menstrual periods and pain during intercourse.
Standard test for blood sugar control not accurate in diabetic dialysis patients
The standard test for measuring blood sugar control in people with diabetes is not accurate in those on kidney hemodialysis, according to new research at Wake Forest University Baptist Medical Center.
Snow skiing is a great, low-impact workout for healthy seniors
Snow skiing may be an X Games sport, but for Gail McLeod and her husband, John, getting out on the slopes is just another way to exercise and enjoy nature with their friends.
Doctors warn patients of HPV link to oral cancer
Ten years ago, most of Dr. Brian Nussenbaum's oral cancer patients were men over 60 who used tobacco and drank heavily. Today, his patients with oral cancer look different. And so does the risky behavior that seems to be leading to their cancer.
[Home]
[Full version]